无他汀类药物治疗适应证的亚临床冠状动脉粥样硬化患者的胆固醇控制。
Cholesterol Control for Subclinical Coronary Atherosclerosis in Subjects Without Indication for Statin Therapy.
机构信息
Department of Cardiology, Soon Chun Hyang University Hospital Bucheon, Bucheon, Korea.
Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
出版信息
Am J Cardiol. 2021 Aug 15;153:51-57. doi: 10.1016/j.amjcard.2021.05.019. Epub 2021 Jun 24.
Low-risk individuals still experience adverse cardiac events. We sought to evaluate long-term cardiac events and predictors for subclinical coronary atherosclerosis in subjects without indication for statin therapy. We analyzed 3,272 individuals without indication for statin therapy who voluntarily underwent coronary computed tomography angiography as part of a general health examination. A cardiac event was defined as a composite of cardiac death, nonfatal myocardial infarction, unstable angina requiring hospitalization, or late coronary revascularization. The prevalence of normal coronary arteries, nonobstructive coronary artery disease (CAD) (diameter stenosis < 50%), and obstructive CAD (diameter stenosis ≥50%) was 2,338 (71.5%), 809 (24.7%), and 125 (3.8%), respectively. During the follow-up period (median 5.3 [interquartile range, 4.3-6.3] years), the 6-year event-free survival rates were 99.2%±0.2% in subjects with normal coronary arteries, 98.2%±0.6% in those with nonobstructive CAD, and 90.2%±2.7% in those with obstructive CAD (log-rank p < 0.001). Multivariable regression analysis showed that low-density lipoprotein cholesterol (LDL-C, odds ratio [OR]: 1.012; 95% confidence interval (CI): 1.005-1.019) and high-density lipoprotein cholesterol (HDL-C, OR: 0.968; 95% CI: 0.952-0.984) levels were associated with subclinical obstructive CAD, together with age (OR: 1.080; 95% CI: 1.040-1.121) and male sex (OR: 3.102; 95% CI: 1.866-5.155) (all p < 0.05). In conclusion, LDL-C and HDL-C are significantly associated with the presence of subclinical obstructive CAD with a worse prognosis in subjects without indication for statin therapy. These findings suggest that stricter control of LDL-C and HDL-C levels may be necessary for primary prevention even in a relatively low-risk population.
低危个体仍会发生不良心脏事件。我们旨在评估无他汀类药物治疗指征人群的亚临床冠状动脉粥样硬化的长期心脏事件和预测因素。我们分析了 3272 名无他汀类药物治疗指征的自愿接受冠状动脉计算机断层扫描血管造影作为一般健康检查一部分的个体。心脏事件定义为心脏死亡、非致死性心肌梗死、需要住院的不稳定型心绞痛或晚期冠状动脉血运重建的复合事件。正常冠状动脉、非阻塞性冠状动脉疾病(CAD)(直径狭窄<50%)和阻塞性 CAD(直径狭窄≥50%)的患病率分别为 2338 例(71.5%)、809 例(24.7%)和 125 例(3.8%)。在随访期间(中位数 5.3[四分位距,4.3-6.3]年),正常冠状动脉、非阻塞性 CAD 和阻塞性 CAD 患者的 6 年无事件生存率分别为 99.2%±0.2%、98.2%±0.6%和 90.2%±2.7%(对数秩检验 p<0.001)。多变量回归分析显示,低密度脂蛋白胆固醇(LDL-C)(比值比[OR]:1.012;95%置信区间[CI]:1.005-1.019)和高密度脂蛋白胆固醇(HDL-C)(OR:0.968;95%CI:0.952-0.984)水平与亚临床阻塞性 CAD 相关,与年龄(OR:1.080;95%CI:1.040-1.121)和男性(OR:3.102;95%CI:1.866-5.155)相关(均 p<0.05)。总之,在无他汀类药物治疗指征的个体中,LDL-C 和 HDL-C 与亚临床阻塞性 CAD 的存在显著相关,预后较差。这些发现表明,即使在相对低危人群中,也需要更严格地控制 LDL-C 和 HDL-C 水平以进行一级预防。